Indications Ischemic heart disease and any clinical situation in which platelet aggregation inhibition is indicated prevention of myocardial infarction in high-risk patients; fresh myocardial infarction or suspected fresh myocardial infarction; unstable angina; secondary prevention in post-myocardial infarction patients; status following coronary artery bypass grafting, coronary angioplasty; prevention of transient cerebral ischemic attack (TIA) and ischemic stroke in patients with TIA; after ischemic stroke in patients with TIA; in patients with peripheral arteriosclerosis; prevention of coronary thrombosis in patients with multiple risk factors; prevention of venous thrombosis and pulmonary embolism in patients with long-term immobilization, e.g. The use of acetylsalicylic acid is not recommended in patients with multiple risk factors; prevention of venous thrombosis and pulmonary embolism in patients who are immobile for long periods, e.g., after major surgery, as an adjunct to other forms of prophylaxis. Dosage Oral administration. Acard enteral tablets are encapsulated and do not disintegrate in the stomach, thereby reducing the irritating effect of acetylsalicylic acid on the gastric mucosa.
Enteral tablets should be taken after a meal - swallow whole. Note: in fresh myocardial infarction or suspected fresh myocardial infarction, enteral tablets may be used when acetylsalicylic acid in uncoated tablets is not available. In this case, the enteral tablets should be chewed very thoroughly to achieve rapid absorption. Prevention of myocardial infarction in high-risk individuals: Usually 1 enteral tablet (75 mg) per day. Fresh myocardial infarction or suspected fresh myocardial infarction: 4 enteral tablets (300 mg) at a time. The enteral tablets should be chewed very thoroughly to achieve rapid absorption! Unstable coronary artery disease, secondary prevention in patients after myocardial infarction: Usually 1 enteral tablet (75 mg) per day. Condition after coronary artery bypass grafting, coronary angioplasty: Usually 1 enteral tablet (75 mg) per day. Prevention of transient cerebral ischemia (TIA) attacks and ischemic stroke in patients with TIA (transient ischaemic stroke). TIA - transient ischaemic attacks): Usually 1 enteral tablet (75 mg) per day. After ischaemic stroke in patients with TIA: 1 enteral tablet (75 mg) per day. In patients with peripheral arteriosclerosis: Usually 1 enteral tablet (75 mg) daily. Prevention of coronary thrombosis in patients with multiple risk factors: Recommended daily dose of 1 to 2 enteral tablets (75 mg to 150 mg). Prevention of venous thrombosis and pulmonary embolism in patients with prolonged immobilization, such as after major surgery as an adjunct to other modes of prophylaxis: 1 to 2 enteral tablets (75 mg to 150 mg) per day. Composition One enteral tablet contains 75 mg of acetylsalicylic acid (Acidum acetylsallicum).
